Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Prophylaxis in Men and Transgender Women Who Have Sex With Men and Are At Risk of HIV-1 Infection
Clinical trial NCT02842086 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02842086
- Sponsor
- Gilead Sciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-02
- Primary completion
- 2019-01-31
- Enrollment
- 5399
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.